Newsroom

WASHINGTON – Today, U.S. Rep. Diana DeGette (CO-1) presided as Ranking Member of the Oversight and Investigation Subcommittee's hearing investigating last October's fungal meningitis outbreak and the lack of sufficient regulation over the compounding pharmacy industry. The outbreak was caused by contaminated steroid injections manufactured at the New England Compounding Company (NECC).

WASHINGTON – U.S. Rep. Diana DeGette (CO-1) issued the following statement after voting against Senate Amendment to H.R. 933, a Continuing Resolution that funds the federal government through September 30th of this year.

WASHINGTON – Today, U.S. Representatives Diana DeGette (D-CO) and Ed Whitfield (R-KY), Co-chairs of the Congressional Diabetes Caucus, introduced the Access to Quality Diabetes Education Act, and the Preventing Diabetes in Medicare Act. Both bills provide critical support to Medicare beneficiaries who are diabetic or prediabetic.

WASHINGTON – Today, U.S. Rep. Diana DeGette (CO01) released the following statement on the Food and Drug Administration's (FDA) study conducted by the Institute of Food Technologists (IFT) on pilot projects for improving product tracing along the food supply system. DeGette was a leading advocate for passage of the Food Safety Modernization Act (FSMA), and in particular, the inclusion of traceability as a fundamental component to improve our nation's food safety system.